“…However, these platinum-based complexes have encountered much resistance and exhibited severe side effects, e.g., nephrotoxicity and neurotoxicity. , Consequently, to overcome these limitations, a significant number of alternative metal- and organometal-based − anticancer drugs were developed. In this respect, among the main-group metal compounds, organotin(IV) compounds have attracted more consideration due to their pharma value and biological activity. − In some cases, they are more effective than cisplatin in vitro tests and exhibit the most effective antitumor activities. , To date, a substantial number of organotin(IV) compounds have been tested as antitumor agents. ,,, Also, it is documented that their cytotoxicity is employed by the apoptosis mode via different pathways, e.g., interaction with DNA, change in the Ca 2+ homeostasis, caspase modulation, and so on. Furthermore, as compared to the mononuclear organotin complexes, di- or polynuclear organotin complexes have several advantages.…”